606 related articles for article (PubMed ID: 25394824)
21. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
22. Access to Personal Health Records and Screening for Breast and Cervical Cancer Among Women with a Family History of Cancer.
Kim H; Mahmood A; Carlton E; Goldsmith J; Chang C; Bhuyan S
J Cancer Educ; 2020 Dec; 35(6):1128-1134. PubMed ID: 31264113
[TBL] [Abstract][Full Text] [Related]
23. The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.
Willems B; Bracke P
BMC Health Serv Res; 2018 Dec; 18(1):943. PubMed ID: 30514273
[TBL] [Abstract][Full Text] [Related]
24. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
Coughlin SS; King J
BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
Guo F; Hirth JM; Berenson AB
Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
[TBL] [Abstract][Full Text] [Related]
26. Determinants of Breast and Cervical Cancer Screening Uptake Among Women in Turkey.
Sözmen K; Unal B; Sakarya S; Dinc G; Yardim N; Keskinkilic B; Ergör G
Asia Pac J Public Health; 2016 Sep; 28(6):528-38. PubMed ID: 27354286
[TBL] [Abstract][Full Text] [Related]
27. Cancer screening in women: body mass index and adherence to physician recommendations.
Ferrante JM; Chen PH; Crabtree BF; Wartenberg D
Am J Prev Med; 2007 Jun; 32(6):525-31. PubMed ID: 17533069
[TBL] [Abstract][Full Text] [Related]
28. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain).
Borràs JM; Guillen M; Sánchez V; Juncà S; Vicente R
Eur J Cancer Prev; 1999 Oct; 8(5):427-34. PubMed ID: 10548398
[TBL] [Abstract][Full Text] [Related]
29. Barriers to breast and cervical cancer screening for women with physical disability: A review.
Ramjan L; Cotton A; Algoso M; Peters K
Women Health; 2016; 56(2):141-56. PubMed ID: 26325597
[TBL] [Abstract][Full Text] [Related]
30. Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey.
Petrelli A; Giorgi Rossi P; Francovich L; Giordani B; Di Napoli A; Zappa M; Mirisola C; Gargiulo L
BMJ Open; 2018 Sep; 8(9):e021653. PubMed ID: 30232106
[TBL] [Abstract][Full Text] [Related]
31. Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the National Health Interview Survey 2008, 2010, and 2013.
Shoemaker ML; White MC
Cancer Causes Control; 2016 Mar; 27(3):453-7. PubMed ID: 26809510
[TBL] [Abstract][Full Text] [Related]
32. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013.
Theme Filha MM; Leal MD; Oliveira EF; Esteves-Pereira AP; Gama SG
Int J Equity Health; 2016 Nov; 15(1):136. PubMed ID: 27852313
[TBL] [Abstract][Full Text] [Related]
33. Do cervical cancer screening rates increase in association with an intervention designed to increase mammography usage?
Katz ML; Tatum CM; Degraffinreid CR; Dickinson S; Paskett ED
J Womens Health (Larchmt); 2007; 16(1):24-35. PubMed ID: 17324094
[TBL] [Abstract][Full Text] [Related]
34. Validity of women's self-reports of cancer screening test utilization in a managed care population.
Caplan LS; McQueen DV; Qualters JR; Leff M; Garrett C; Calonge N
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1182-7. PubMed ID: 14652278
[TBL] [Abstract][Full Text] [Related]
35. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
36. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
Phaswana-Mafuya N; Peltzer K
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
[TBL] [Abstract][Full Text] [Related]
37. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
Horner-Johnson W; Dobbertin K; Iezzoni LI
Womens Health Issues; 2015; 25(3):246-53. PubMed ID: 25864023
[TBL] [Abstract][Full Text] [Related]
38. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
Luque JS; Tarasenko YN; Chen C
J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
[TBL] [Abstract][Full Text] [Related]
39. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
Katz SJ; Hofer TP
JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
[TBL] [Abstract][Full Text] [Related]
40. Breast and cervical cancer screening disparities associated with disability severity.
Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
